ArticleFrontiers in medicine2026
Burden and clinical impact of anemia in heart failure: insights from a large observational cohort in Saudi Arabia.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anemia is a common comorbidity in heart failure (HF) and is associated with adverse outcomes, yet contemporary real-world data describing its burden and relationship with biomarkers of HF severity remain limited. Objectives: To evaluate the prevalence and severity of anemia in patients with HF, identify independent predictors, and examine the association between hemoglobin levels and B-type natriuretic peptide (BNP). Methods: We conducted a multicenter retrospective cohort study of adult patients with HF across National Guard Health Affairs hospitals in Saudi Arabia. Anemia was categorized as mild, moderate, or severe based on hemoglobin levels. Clinical characteristics, laboratory parameters, and outcomes were compared by anemia status and severity. Multivariable logistic regression identified independent predictors of anemia. Correlation and linear regression analyses assessed the relationship between hemoglobin and BNP, adjusting for age, sex, chronic kidney disease (CKD), and estimated glomerular filtration rate (eGFR). Results: Among 2,144 patients (median age 67 years; 50.8% female), anemia was present in 56.4% (95% CI 54.3%-58.5%), with moderate anemia most common (53.2%). Increasing anemia severity was associated with older age, longer HF duration, higher prevalence of CKD and atrial fibrillation, worsening renal function, hypoalbuminemia, and progressively higher BNP and troponin levels (all Conclusion: Anemia is highly prevalent in HF and closely linked to disease severity, adverse clinical profiles, and increased cardiovascular mortality, supporting routine anemia assessment in comprehensive HF care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.